MAPT and Alzheimer disease: A quantitative proteomics study analyzed the detergent-soluble and insoluble fractions from AD brain tissue to characterize tau and Aβ species by biochemical assays, electron microscopy, and targeted mass spectrometry analysis [73] (Table 4).